BMS-986301

BMS-986301 · Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BMS-986301, covering 2025-02-19 to 2025-02-19. Get the full timeline:

Most recent: Clinical Trial Update: An Investigational Immunotherapy Study of BMS-986301 Alone or in Combination With Nivolumab, and Ipilimumab in Participants With Advanced Solid Cancers [Phase 1]

See pricing